ASCO 2026: Latest updates in mRCC
Ulrich Jager speaks with ecancer at EAPM 2017.
He talks about how diagnostic developments have led to a diversity of diseases in the haematological field.
He discusses new research concerning how the tumour reacts to a drug, and how to make decisions in a 'post-genomic era'.
ASCO 2026: Latest updates in mRCC
Burden and trends of breast cancer worldwide: Opportunities for prevention?
Key insights from lung cancer research at ASCO 2025
Advancements in paediatric Acute lymphoblastic leukemia management
ESMO 2024: Optimising the personalisation of prostate cancer treatment
Hormonal receptor positive breast cancer adjuvant and metastatic indications
ASCO 2024: Lung cancer highlights
EAU 2024: Bladder cancer latest
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus